| Product NDC: | 68828-106 |
| Proprietary Name: | Jafra |
| Non Proprietary Name: | Titanium Dioxide, Octinoxate |
| Active Ingredient(s): | 2; 6.4 mL/80mL; mL/80mL & nbsp; Titanium Dioxide, Octinoxate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68828-106 |
| Labeler Name: | Jafra Cosmetics International Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20120730 |
| Package NDC: | 68828-106-02 |
| Package Description: | 10 BOTTLE in 1 PACKAGE (68828-106-02) > 8 mL in 1 BOTTLE (68828-106-01) |
| NDC Code | 68828-106-02 |
| Proprietary Name | Jafra |
| Package Description | 10 BOTTLE in 1 PACKAGE (68828-106-02) > 8 mL in 1 BOTTLE (68828-106-01) |
| Product NDC | 68828-106 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Titanium Dioxide, Octinoxate |
| Dosage Form Name | LIQUID |
| Route Name | TOPICAL |
| Start Marketing Date | 20120730 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Jafra Cosmetics International Inc |
| Substance Name | OCTINOXATE; TITANIUM DIOXIDE |
| Strength Number | 2; 6.4 |
| Strength Unit | mL/80mL; mL/80mL |
| Pharmaceutical Classes |